Health & Biotech
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
Health & Biotech
ASX Health Stocks: Aussie biotechs Argenica and Antisense take major steps in the US
Health & Biotech
Wellnex Life signs JV with Australian Dairy to launch A2 infant formula across shelves
Health & Biotech
Cannabis play Epsilon boosted by $2.9m fresh capital as it targets profit in 2022
Health & Biotech
HealthKick Podcast: Life sciences expert on local medical innovations, tech leaders and sector opportunities
Health & Biotech
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
Health & Biotech
Neuren’s stock price doubles on groundbreaking drug trial, CEO says it’s ‘just getting started’
Health & Biotech
Weed Week: An Aussie company mistakenly named in Taliban weed deal and new research could shake up cannabis driving laws
Health & Biotech
ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results
Health & Biotech
Mesoblast has long been the one poster child for stem cell therapy. Now Cynata and other ASX stocks have emerged
Health & Biotech
ASX medtech CardieX accelerates go-to-market strategy following strong Options take up
Health & Biotech
ASX Health Stocks: Sigma downgrades earnings, and chairman’s death at Asian American Medical
Health & Biotech
EZZ appoints veteran biotechnology industry player Glenn Cross as chairman
Health & Biotech
Osteopore granted key regulatory approval in Hong Kong
Health & Biotech
ScoPo’s Powerplays: IDT wins big on COVID vaccines, but Healthcare IPOs look exhausted
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.